Dry Labs Threaten Manufacturer GMP Compliance, Reputation
This article was originally published in The Tan Sheet
Recent media reports push to the forefront the threat posed by dry labs that falsely claim to test products for manufacturers. Manufacturers should qualify and regularly audit labs to reduce this risk, which places them on the hook for potential GMP violations, industry leaders say.
You may also be interested in...
Shipping product once found to be contaminated, but later rated as safe in tests by a second source is not a good manufacturing practice, according to FDA
J&J reports worldwide consumer sales dipped 0.6% to $3.6 billion despite retailers buying more upper respiratory and analgesic products to prepare for the cough and cold season. But in key OTC categories the firm is regaining market share it lost when its iconic brands were temporarily not available.
GlaxoSmithKline restructures its management to ensure adequate focus on its three core areas, pharmaceutical, vaccine and consumer. Consumer product sales fell 3% to $1.72 billion in the third quarter due to continuing supply interruptions and generally weaker markets.